Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Gastroesophageal Junction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04999332
What this trial is testing

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaEffects of Chemotherapy+1 more
National Cheng-Kung University Hospital 58
Early research (Phase 1)Study completedNCT03821233
What this trial is testing

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Who this might be right for
HER2-expressing Cancers
Zymeworks BC Inc. 112
Testing effectiveness (Phase 2)UnknownNCT05594381
What this trial is testing

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Who this might be right for
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 90
Large-scale testing (Phase 3)Active Not RecruitingNCT01924819
What this trial is testing

Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Australasian Gastro-Intestinal Trials Group 574
Testing effectiveness (Phase 2)Study completedNCT02335411
What this trial is testing

Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC 318
Not applicableActive Not RecruitingNCT07663786
What this trial is testing

Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice

Who this might be right for
Esophageal AdenocarcinomaGastro-esophageal Junction AdenocarcinomaGastric Adenocarcinoma
Bristol-Myers Squibb 726
Post-approval studies (Phase 4)Not Yet RecruitingNCT07768358
What this trial is testing

Tucatinib Continuation Study

Who this might be right for
HER2-positive Breast CancerCervical CancerBiliary Tract Neoplasms+4 more
Pfizer 175
Early research (Phase 1)UnknownNCT06353152
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Peking University 12
Not applicableStudy completedNCT01216813
What this trial is testing

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577376
What this trial is testing

A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaExpressing Human Epidermal Growth Factor Receptor-2 (HER-2)Disease Progression After Receiving at Least One and at Most Two Lines of Systemic Treatment in the Past
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Not applicableWithdrawnNCT00372450
What this trial is testing

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastrointestinal Complications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Testing effectiveness (Phase 2)Study completedNCT03008278
What this trial is testing

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Esophageal CarcinomaMetastatic Gastric CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+10 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT01246960
What this trial is testing

Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Who this might be right for
Stomach CancerEsophageal Cancer
Eli Lilly and Company 168
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT01095120
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Genta Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT00517829
What this trial is testing

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
US Oncology Research 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07772557
What this trial is testing

Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 108
Not applicableLooking for participantsNCT06558786
What this trial is testing

Registry for Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal-junction CancerEsophageal Cancer
Memorial Sloan Kettering Cancer Center 50
Next Page
252